Speidel Daniel
Children's Medical Research Institute, 214 Hawkesbury Road, Westmead, NSW, 2145, Australia,
Arch Toxicol. 2015 Apr;89(4):501-17. doi: 10.1007/s00204-015-1459-z. Epub 2015 Jan 25.
The tumour suppressor p53 is a central player in cellular DNA damage responses. P53 is upregulated and activated by genotoxic stress and induces a transcriptional programme with effectors promoting apoptosis, cell cycle arrest, senescence and DNA repair. For the best part of the last three decades, these DNA damage-related programmes triggered by p53 were unequivocally regarded as the major if not sole mechanism by which p53 exerts its tumour suppressor function. However, this interpretation has been challenged by a number of recent in vivo studies, demonstrating that mice which are defective in inducing p53-dependent apoptosis, cell cycle arrest and senescence suppress thymic lymphoma as well as wild-type p53 expressing animals. Consequently, the importance of DNA damage responses for p53-mediated tumour suppression has been questioned. In this review, I summarize current knowledge on p53-controlled DNA damage responses and argue that these activities, while their role has certainly changed, remain an important feature of p53 biology with relevance for cancer therapy and tumour suppression.
肿瘤抑制因子p53是细胞DNA损伤反应中的核心角色。p53在基因毒性应激作用下上调并被激活,进而诱导一个转录程序,该程序中的效应因子可促进细胞凋亡、细胞周期阻滞、衰老及DNA修复。在过去三十年的大部分时间里,由p53触发的这些与DNA损伤相关的程序被明确认为是p53发挥其肿瘤抑制功能的主要机制,即便不是唯一机制。然而,最近的一些体内研究对这一解释提出了挑战,这些研究表明,在诱导p53依赖性细胞凋亡、细胞周期阻滞和衰老方面存在缺陷的小鼠与表达野生型p53的动物一样,都能抑制胸腺淋巴瘤。因此,DNA损伤反应对p53介导的肿瘤抑制作用的重要性受到了质疑。在这篇综述中,我总结了目前关于p53控制的DNA损伤反应的知识,并认为这些活动虽然其作用肯定发生了变化,但仍然是p53生物学的一个重要特征,与癌症治疗和肿瘤抑制相关。